CNS pipeline · person

Aaron Koenig, M.D.

Appointed Chief Medical Officer of Syndeio Biosciences on 2025-11-04. Board-certified by the American Board of Psychiatry and Neurology; previously Chief Medical Officer at Delix Therapeutics and held leadership roles at Sage Therapeutics overseeing neuropsychiatry programs including NMDAR-targeted candidates.

0 companies

Past roles

Syndeio Biosciences, Inc.Chief Medical Officer · Executive

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.